Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "antiphospholipid Antibodies"

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Manganelli, Valeria ^a   Capozzi, Antonella ^a   Recalchi, Serena ^a   Signore, Michele ^b   Mattei, Vincenzo ^a,c   Garofalo, Tina ^a   Misasi, Roberta ^a   Degli Esposti, Mauro ^d   Sorice, Maurizio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Sabina Universitas   (Italy)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; PHOSPHOLIPID ANTIBODY; VIMENTIN; PHOSPHOLIPID; PROTEIN BINDING;

APOPTOSIS; CELL SURFACE; CONFOCAL MICROSCOPY; CYTOFLUOROMETRY; HUMAN; INTRACELLULAR MEMBRANE; MITOCHONDRION; OLIGOMERIZATION; PROTEIN INTERACTION; REVIEW; ANIMAL; CELL MEMBRANE; CYTOSKELETON; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; APOPTOSIS; BIOLOGICAL TRANSPORT; CARDIOLIPINS; CELL MEMBRANE; CYTOSKELETON; HUMANS; MITOCHONDRIA; PHOSPHOLIPIDS; PROTEIN BINDING; SIGNAL TRANSDUCTION; VIMENTIN;

EID: 84944237961     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/847985     Document Type: Review

References (104)

1. J. F. Kerr, A. H. Wyllie, and A. R. Currie, "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics," British Journal of Cancer, vol. 26, no. 4, pp. 239-257, 1972
2. G. Häcker, "The morphology of apoptosis," Cell and Tissue Research, vol. 301, no. 1, pp. 5-17, 2000
3. M. O. Hengartner, "The biochemistry of apoptosis," Nature, vol. 407, no. 6805, pp. 770-776, 2000
4. P. Boya, K. Andreau, D. Poncet et al., "Lysosomal membrane permeabilization induces cell death in a mitochondriondependent fashion,"The Journal of Experimental Medicine, vol. 197, no. 10, pp. 1323-1334, 2003
5. M. C. Peitsch, H. G. Mannherz, and J. Tschopp, "The apoptosis endonucleases: cleaning up after cell death" Trends in Cell Biology, vol. 4, no. 2, pp. 37-41, 1994
6. R. C. Taylor, S. P. Cullen, and S. J. Martin, "Apoptosis: controlled demolition at the cellular level," Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 231-241, 2008
7. I. M. Cristea and M. D. Esposti, "Membrane lipids and cell death: an overview," Chemistry and Physics of Lipids, vol. 129, no. 2, pp. 133-160, 2004
8. A. Yamaji-Hasegawa and M. Tsujimoto, "Asymmetric distribution of phospholipids in biomembranes," Biological and Pharmaceutical Bulletin, vol. 29, no. 8, pp. 1547-1553, 2006
9. V. A. Fadok,D. R. Voelker, P. A. Campbell, J. J. Cohen,D. L. Bratton, and P. M. Henson, "Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages," The Journal of Immunology, vol. 148, no. 7, pp. 2207-2216, 1992
10. S. J. Martin, C. P. M. Reutelingsperger, A. J. McGahon et al., "Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 andAbl," Journal of Experimental Medicine, vol. 182, no. 5, pp. 1545-1556, 1995
11. V. A. Fadok, D. L. Bratton, D. M. Rose, A. Pearson, R. A. B. Ezekewitz, and P. M. Henson, "A receptor for phosphatidylserine-specific clearance of apoptotic cells," Nature, vol. 405, no. 6782, pp. 85-90, 2000
12. J. E. Mitchell,M. Cvetanovic, N. Tibrewal et al., "The presumptive phosphatidylserine receptor is dispensable for innate antiinflammatory recognition and clearance of apoptotic cells," The Journal of Biological Chemistry, vol. 281, no. 9, pp. 5718-5725, 2006
13. J. Liu, R. F. Epand, D. Durrant et al., "Role of phospholipid scramblase 3 in the regulation of tumor necrosis factor-alphainduced apoptosis," Biochemistry, vol. 47, no. 15, pp. 4518-4529, 2008
14. M. Sorice, A. Circella, R. Misasi et al., "Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipid antibodies," Clinical and Experimental Immunology, vol. 122, no. 2, pp. 277-284, 2000
15. M. Crimi and M. D. Esposti, "Apoptosis-induced changes in mitochondrial lipids," Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 551-557, 2011
16. N. Zamzami, S. A. Susin, P. Marchetti et al., "Mitochondrial control of nuclear apoptosis," The Journal of Experimental Medicine, vol. 183, no. 4, pp. 1533-1544, 1996
17. J.-L. Vayssière, P. X. Petit, Y. Risler, and B. Mignotte, "Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 91,no. 24,pp. 11752-11756, 1994
18. P. X. Petit, H. Lecoeur, E. Zorn, C. Dauguet, B. Mignotte, and M.-L. Gougeon, "Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis," Journal of Cell Biology, vol. 130, no. 1, pp. 157-167, 1995
19. D. M. Hockenbery, Z. N. Oltvai, X.-M. Yin, C. L. Milliman, and S. J. Korsmeyer, "Bcl-2 functions in an antioxidant pathway to prevent apoptosis," Cell, vol. 75, no. 2, pp. 241-251, 1993
20. A. Boveris and B. Chance, "The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen," Biochemical Journal, vol. 134, no. 3, pp. 707-716, 1973
21. L. A. Casciola-Rosen, D. K. Miller, G. J. Anhalt, and A. Rosen, "Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death," The Journal of Biological Chemistry, vol. 269, no. 49, pp. 30757-30760, 1994
22. C. A. Casiano, S. J. Martin, D. R. Green, and E. M. Tan, "Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis," The Journal of Experimental Medicine, vol. 184, no. 2, pp. 765-770, 1996
23. A. Macho, M. Castedo, P. Marchetti et al., "Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers," Blood, vol. 86, no. 7, pp. 2481-2487, 1995
24. M. Schlame, D. Rua, and M. L. Greenberg, "The biosynthesis and functional role of cardiolipin," Progress in Lipid Research, vol. 39, no. 3, pp. 257-288, 2000
25. P. Moreau and C. Cassagne, "Phospholipid trafficking and membrane biogenesis," Biochimica et Biophysica Acta, vol. 1197, no. 3, pp. 257-290, 1994
26. A. Zachowski, "Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement," Biochemical Journal, vol. 294, no. 1, pp. 1-14, 1993
27. S. Ouasti, P. Matarrese, R. Paddon et al., "Death receptor ligation triggers membrane scrambling between Golgi and mitochondria," Cell Death and Differentiation, vol. 14, no. 3, pp. 453-461, 2007
28. P. Matarrese, V. Manganelli, T. Garofalo et al., "Endosomal compartment contributes to the propagation of CD95/Fasmediated signals in type II cells," Biochemical Journal, vol. 413, no. 3, pp. 467-478, 2008
29. M. Degli Esposti, "Organelle intermixing and membrane scrambling in cell death," Methods in Enzymology, vol. 442, pp. 421-438, 2008
30. N. C. Robinson, "Functional binding of cardiolipin to cytochrome c oxidase," Journal of Bioenergetics and Biomembranes, vol. 25, no. 2, pp. 153-163, 1993
31. B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose, "Autoantibodies to vimentin cause accelerated rejection of cardiac allografts," The American Journal of Pathology, vol. 170, no. 4, pp. 1415-1427, 2007
32. R. H. Houtkooper and F. M. Vaz, "Cardiolipin, the heart of mitochondrial metabolism," Cellular and Molecular Life Sciences, vol. 65, no. 16, pp. 2493-2506, 2008
33. E. Mileykovskaya, M. Zhang, and W. Dowhan, "Cardiolipin in energy transducingmembranes," Biochemistry, vol. 70,no. 2, pp. 154-158, 2005
34. D. Ardail, J.-P. Privat, M. Egret-Charlier, C. Levrat, F. Lerme, and P. Louisot, "Mitochondrial contact sites: lipid composition and dynamics,"The Journal of Biological Chemistry, vol. 265, no. 31, pp. 18797-18802, 1990
35. M. G. Fernandez, L. Troiano, L. Moretti et al., "Early changes in intramitochondrial cardiolipin distribution during apoptosis," Cell Growth & Differentiation, vol. 13, no. 9, pp. 449-455, 2002
36. A. J. Chicco and G. C. Sparagna, "Role of cardiolipin alterations in mitochondrial dysfunction and disease," The American Journal of Physiology-Cell Physiology, vol. 292, no. 1, pp. C33-C44, 2007
37. P. Vreken, F. Valianpour, L. G. Nijtmans et al., "Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome," Biochemical and Biophysical Research Communications, vol. 279, no. 2, pp. 378-382, 2000
38. M. W. Fariss, C. B. Chan, M. Patel, B. Van Houten, and S. Orrenius, "Role of mitochondria in toxic oxidative stress," Molecular Interventions, vol. 5, no. 2, pp. 94-111, 2005
39. X. X. Li, B. Tsoi,Y. F. Li, H. Kurihara, and R. R. He, "Cardiolipin and itsdifferent properties inmitophagy and apoptosis," Journal of Histochemistry & Cytochemistry, vol. 63, no. 5, pp. 301-311, 2015
40. F. Gonzalvez and E. Gottlieb, "Cardiolipin: setting the beat of apoptosis," Apoptosis, vol. 12, no. 5, pp. 877-885, 2007
41. T. Kuwana, M. R. Mackey, G. Perkins et al., "Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrialmembrane," Cell, vol. 111, no. 3, pp. 331-342, 2002
42. X. Roucou, S. Montessuit, B. Antonsson, and J.-C. Martinou, "Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein," Biochemical Journal, vol. 368, no. 3, pp. 915-921, 2002
43. M. Degli Esposti, I. M. Cristea, S. J. Gaskell, Y. Nakao, and C. Dive, "Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death," Cell Death&Differentiation, vol. 10,no. 12, pp. 1300-1309, 2003
44. F. Gonzalvez, Z. T. Schug, R. H. Houtkooper et al., "Cardiolipin provides an essential activating platform for caspase-8 on mitochondria," Journal of Cell Biology, vol. 183, no. 4, pp. 681-696, 2008
45. O. Jalmar, A. J. García-Sáez, L. Berland, F. Gonzalvez, and P. X. Petit, "Giant unilamellar vesicles (GUVs) as a new tool for analysis of caspase-8/Bid-FL complex binding to cardiolipin and its functional activity," Cell Death and Disease, vol. 1, no. 12, article e103, 2010
46. O. Jalmar, L. François-Moutal, A.-J. García-Sáez et al., "Caspase-8 binding to cardiolipin in giant unilamellar vesicles provides a functional docking platform for Bid," PLoS ONE, vol. 8, no. 2, Article ID e55250, 2013
47. C. Kantari and H. Walczak, "Caspase-8 and Bid: caught in the act between death receptors and mitochondria," Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 558-563, 2011
48. Z. T. Schug and E. Gottlieb, "Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis," Biochimica et Biophysica Acta, vol. 1788, no. 10, pp. 2022-2031, 2009
49. K. J. Oh, S. Barbuto, N. Meyer, R.-S. Kim, R. J. Collier, and S. J. Korsmeyer, "Conformational changes in BID, a proapoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study," The Journal of Biological Chemistry, vol. 280, no. 1, pp. 753-767, 2005
50. T. Garofalo, A. M. Giammarioli, R. Misasi et al., "Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells," Cell Death & Differentiation, vol. 12, no. 11, pp. 1378-1389, 2005
51. W. Malorni, T. Garofalo, A. Tinari et al., "Analyzing lipid raft dynamics during cell apoptosis," Methods in Enzymology, vol. 442, pp. 125-140, 2008
52. W. Malorni, A. M. Giammarioli, T. Garofalo, and M. Sorice, "Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3," Apoptosis, vol. 12, no. 5, pp. 941-949, 2007
53. T. Garofalo, A. Tinari, P. Matarrese et al., "Do mitochondria act as 'cargo boats' in the journey of GD3 to the nucleus during apoptosis" FEBS Letters, vol. 581, no. 21, pp. 3899-3903, 2007
54. M. Sorice, V. Manganelli, P. Matarrese et al., "Cardiolipinenriched raft-like microdomains are essential activating platforms for apoptotic signals onmitochondria," FEBS Letters, vol. 583, no. 15, pp. 2447-2450, 2009
55. M. Karbowski, Y.-J. Lee, B. Gaume et al., "Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis," Journal of Cell Biology, vol. 159, no. 6, pp. 931-938, 2002
56. R. Hovius, J. Thijssen, P. van der Linden, K. Nicolay, and B. de Kruijff, "Phospholipid asymmetry of the outermembrane of rat liver mitochondria. Evidence for the presence of cardiolipin on the outside of the outer membrane," FEBS Letters, vol. 330, no. 1, pp. 71-76, 1993
57. K. Nicolay, M. Rojo, T. Wallimann, R. Demel, and R. Hovius, "The role of contact sites between inner and outer mitochondrial membrane in energy transfer," Biochimica et Biophysica Acta, vol. 1018, no. 2-3, pp. 229-233, 1990
58. R. Hovius, H. Lambrechts, K. Nicolay, and B. de Kruijff, "Improvedmethods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outermembrane," Biochimica et Biophysica Acta, vol. 1021, no. 2, pp. 217-226, 1990
59. M. Lutter, M. Fang, X. Luo, M. Nishijima, X.-S. Xie, and X. Wang, "Cardiolipin provides specificity for targeting of tBid to mitochondria," Nature Cell Biology, vol. 2, no. 10, pp. 754-756, 2000
60. T. K. Rostovtseva, H. Boukari, A. Antignani et al., "Bax activates endophilin B1 oligomerization and lipid membrane vesiculation," The Journal of Biological Chemistry, vol. 284, no. 49, pp. 34390-34399, 2009
61. A. Manara, J. Lindsay, M. Marchioretto, A. Manara et al., "Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo," Biochimica et Biophysica Acta, vol. 1791, no. 10, pp. 997-1010, 2009
62. G. Kudla, S. Montessuit, R. Eskes et al., "The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved Bid is inhibited by the N-terminal fragment," The Journal of Biological Chemistry, vol. 275, no. 30, pp. 22713-22718, 2000
63. M. Grinberg, R. Sarig, Y. Zaltsman et al., "tBID homooligomerizes in the mitochondrial membrane to induce apoptosis," The Journal of Biological Chemistry, vol. 277, no. 14, pp. 12237-12245, 2002
64. M. Sorice, A. Circella, I. M. Cristea et al., "Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis," Cell Death and Differentiation, vol. 11, no. 10, pp. 1133-1145, 2004
65. M. D. Esposti, J. T. Erler, J. A. Hickman, and C. Dive, "Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity," Molecular and Cellular Biology, vol. 21, no. 21, pp. 7268-7276, 2001
66. D. B. Ostrander, G. C. Sparagna, A. A. Amoscato, J. B. McMillin, andW. Dowhan, "Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis,"The Journal of Biological Chemistry, vol. 276, no. 41, pp. 38061-38067, 2001
67. K. Nomura, H. Imai, T. Koumura, T. Kobayashi, and Y. Nakagawa, "Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis," Biochemical Journal, vol. 351, no. 1, pp. 183-193, 2000
68. J.-C. Martinou and D. R. Green, "Breaking the mitochondrial barrier," Nature Reviews Molecular Cell Biology, vol. 2, no. 1, pp. 63-67, 2001
69. G.-I. Atsumi,M. Tajima, A. Hadano, Y. Nakatani, M. Murakami, and I. Kudot, "Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation," The Journal of Biological Chemistry, vol. 273, no. 22, pp. 13870-13877, 1998
70. M. Maccarrone, G. Melino, and A. Finazzi-Agrò, "Lipoxygenases and their involvement in programmed cell death," Cell Death & Differentiation, vol. 8, no. 8, pp. 776-784, 2001
71. D. W. Voehringer, D. L. Hirschberg, J. Xiao et al., "Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2680-2685, 2000
72. M. D. Esposti, I. Hatzinisiriou, H. McLennan, and S. Ralph, "Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes," The Journal of Biological Chemistry, vol. 274, no. 42, pp. 29831-29837, 1999
73. J. Huot, F. Houle, S. Rousseau, R. G. Deschesnes, G. M. Shah, and J. Landry, "SAPK2/p38-dependent F-actin reorganization regulates earlymembrane blebbing during stress-induced apoptosis," Journal of Cell Biology, vol. 143, no. 5, pp. 1361-1373, 1998
74. M. D. Esposti, J. Tour, S. Ouasti et al., "Fas death receptor enhances endocytic membrane traffic converging into the golgi region,"Molecular Biology of the Cell, vol. 20, no. 2, pp. 600-615, 2009
75. M. V. Blagosklonny, P. Giannakakou, W. S. El-Deiry et al., "Raf-1/bcl-2 phosphorylation: a step frommicrotubule damage to cell death," Cancer Research, vol. 57, no. 1, pp. 130-135, 1997
76. S. Thébault, D. Gilbert, M. Hubert et al., "Orderly pattern of development of the autoantibody response in (New Zealand White × BXSB)F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry," The Journal of Immunology, vol. 169, no. 7, pp. 4046-4053, 2002
77. E. Ortona, A. Capozzi, T. Colasanti et al., "Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome," Blood, vol. 116, no. 16, pp. 2960-2967, 2010
78. T. Katsumoto, A. Mitsushima, and T. Kurimura, "The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction," Biology of the Cell, vol. 68, no. 2, pp. 139-146, 1990
79. R. D. Goldman, S. Khuon, Y. H. Chou, P. Opal, and P. M. Steinert, "The function of intermediate filaments in cell shape and cytoskeletal integrity," Journal of Cell Biology, vol. 134, no. 4, pp. 971-983, 1996
80. E. Moisan and D. Girard, "Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis," Journal of Leukocyte Biology, vol. 79, no. 3, pp. 489-498, 2006
81. E. Boilard, S. G. Bourgoin, C. Bernatchez, and M. E. Surette, "Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2," Blood, vol. 102, no. 8, pp. 2901-2909, 2003
82. N. Mor-Vaknin, A. Punturieri, K. Sitwala, and D. M. Markovitz, "Vimentin is secreted by activated macrophages," Nature Cell Biology, vol. 5, no. 1, pp. 59-63, 2003
83. T. J. Podor, D. Singh, P. Chindemi et al., "Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface,"The Journal of Biological Chemistry, vol. 277, no. 9, pp. 7529-7539, 2002
84. B. Xu, R. M. deWaal, N. Mor-Vaknin, C. Hibbard, D. M. Markovitz, and M. L. Kahn, "The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature," Molecular and Cellular Biology, vol. 24, no. 20, pp. 9198-9206, 2004
85. A. E. Bryant, C. R. Bayer, J. D. Huntington, and D. L. Stevens, "Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes," The Journal of Infectious Diseases, vol. 193, no. 12, pp. 1685-1692, 2006
86. P. Traub, G. Perides, H. Schimmel, and A. Scherbarth, "Interaction in vitro of nonepithelial intermediate filament proteins with total cellular lipids, individual phospholipids, and a phospholipid mixture," The Journal of Biological Chemistry, vol. 261, no. 23, pp. 10558-10568, 1986
87. C. Alessandri, M. Sorice, M. Bombardieri et al., "Antiphospholipid reactivity against cardiolipinmetabolites occurring during endothelial cell apoptosis," Arthritis Research and Therapy, vol. 8, article no. R180, 2006
88. M. Degli Esposti, "Lipids, cardiolipin and apoptosis: a greasy licence to kill," Cell Death and Differentiation, vol. 9, no. 3, pp. 234-236, 2002
89. L. A. Casciola-Rosen, G. Anhalt, and A. Rosen, "Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes," Journal of Experimental Medicine, vol. 179, no. 4, pp. 1317-1330, 1994
90. A. Lanzavecchia, "How can cryptic epitopes trigger autoimmunity" Journal of ExperimentalMedicine, vol. 181, no. 6,pp. 1945-1948, 1995
91. L. Casciola-Rosen, A. Rosen,M. Petri, andM. Schlissel, "Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus," Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 4, pp. 1624-1629, 1996
92. G. R. V. Hughes, "The anticardiolipin syndrome," Clinical and Experimental Rheumatology, vol. 3, no. 4, pp. 285-286, 1985
93. A. A. Manfredi, P. Rovere, G. Galati et al., "Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies," Arthritis and Rheumatism, vol. 41, no. 2, pp. 205-214, 1998
94. A. A. Manfredi, P. Rovere, S. Heltai et al., "Apoptotic cell clearance in systemic lupus erythematosus. II. Role of 2-glycoprotein I," Arthritis & Rheumatism, vol. 41, no. 2, pp. 215-223, 1998
95. M. Sorice, T. Griggi, A. Circella et al., "Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates," Journal of ImmunologicalMethods, vol. 173, no. 1, pp. 49-54, 1994
96. W. Lim, "Antiphospholipid syndrome," Hematology, vol. 2013, pp. 675-680, 2013
97. E. J. Favaloro and R. C. Wong, "Antiphospholipid antibody testing for the antiphospholipid syndrome," Pathology, vol. 46, no. 6, pp. 481-495, 2014
98. H. P. McNeil, R. J. Simpson, C. N. Chesterman, and S. A. Krilis, "Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: 2-Glycoprotein I (apolipoprotein H)," Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 11, pp. 4120-4124, 1990
99. E. Matsuura, Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike, "Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease,"TheLancet, vol. 336, no. 8708, pp. 177-178, 1990
100. M. A. Blaschek, M. Boehme, J. Jouquan et al., "Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus," Annals of the Rheumatic Diseases, vol. 47, no. 9, pp. 708-716, 1988
101. H. S. Leong, B. M. Mahesh, J. R. Day et al., "Vimentin autoantibodies induce platelet activation and formation of plateletleukocyte conjugates via platelet-activating factor," Journal of Leukocyte Biology, vol. 83, no. 2, pp. 263-271, 2008
102. T. J. Podor, D. Singh, P. Chindemi et al., "Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface," Journal of Biological Chemistry, vol. 277, no. 9, pp. 7529-7539, 2002
103. W. Emlen, J. Niebur, and R. Kadera, "Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus,"The Journal of Immunology, vol. 152, no. 7, pp. 3685-3692, 1994
104. F. Conti, A. Capozzi, S. Truglia et al., "The mosaic of 'seronegative' antiphospholipid syndrome," Journal of Immunology Research, vol. 2014,Article ID 389601, 7 pages, 2014.